Physician
Northern Berkshire Pediatrics, LLP
Northern Berkshire Pediatrics, LLP was paid $1.28M by Medicaid between Jan 2018 and Dec 2024, across 41 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoNORTHERN BERKSHIRE PEDIATRICS, LLP
NORTH ADAMS, MA 01247
NORTH ADAMS, MA 01247
33aNPI1750596201assigned 05/10/2007
33bProvider typePediatrics Physician
28Total paid$1.28M
24GClaims56,725
24DCodes billed41
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#58 of 1,273
Median peer was paid$24K
This provider vs. median53×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,013 | $157K | |
| 2019 | 1,683 | $59K | |
| 2020 | 1,714 | $44K | |
| 2021 | 1,961 | $45K | |
| 2022 | 1,230 | $46K | |
| 2023 | 21,516 | $405K | |
| 2024incomplete | 24,608 | $522K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 15,297 | 14,525 | $286K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 19% | 5,274 | 5,191 | $247K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 7,011 | 6,748 | $166K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 11% | 779 | 698 | $146K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 9.2% | 1,508 | 1,489 | $117K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.4% | 2,420 | 2,401 | $69K |
| 96127 | 4.3% | 4,486 | 4,170 | $55K | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 3.5% | 5,690 | 5,655 | $45K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 2.9% | 264 | 256 | $38K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 1.9% | 109 | 102 | $24K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.8% | 5,268 | 3,029 | $23K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 1,449 | 1,418 | $15K |
29 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 478 | $7K |
| 87634 | <1% | 116 | $7K | |
| 92558 | <1% | 922 | $6K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 675 | $6K |
| 90480 | <1% | 134 | $5K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 369 | $5K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 326 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 200 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 132 | $2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 57 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 284 | $976.78 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 57 | $761.65 |
| 99051 | <1% | 294 | $747.47 | |
| 99173 | <1% | 296 | $568.86 | |
| 94760 | <1% | 151 | $270.02 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 12 | $240.17 |
| 90686 | <1% | 507 | $219.58 | |
| 90461 | <1% | 22 | $151.73 | |
| 90656 | <1% | 404 | $92.77 | |
| 85018 | <1% | 44 | $83.50 | |
| 90473 | <1% | 36 | $75.58 | |
| 90658 | <1% | 144 | $43.37 | |
| 90688 | <1% | 33 | $17.84 | |
| 99072 | 0% | 1,384 | $0.00 | |
| 90670 | 0% | 12 | $0.00 | |
| 90698 | 0% | 12 | $0.00 | |
| 99070 | 0% | 12 | $0.00 | |
| 99417 | Prolong home eval add 15m | 0% | 39 | $0.00 |
| 90660 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKING, SUSAN (PRACTICE MANAGER)